Deloitte introduces Evergreen EHR implementation

Deloitte Healthcare Practice has unveiled Evergreen, a "new approach" to EHR implementation and maintenance designed to help reduce hospital system IT costs as healthcare moves to a value-based model more reliant on clinical and enterprise data.

Evergreen may help health systems save as much as 30 percent on EHR operating costs by using a global staffing model and a standardized design that works to improve clinical optimization, according to a release on the service. Evergreen also leverages Deloitte’s acclaimed cyber risk services in providing advanced levels of data security and compliance.

“Evergreen offers an innovative approach to achieving the expected benefits of clinical and revenue management systems in a post-reform world,” said Mitch Morris, principal of Deloitte Consulting and Deloitte’s global healthcare leader. “It can provide clinicians with the software applications they prefer while supporting the clinical and financial results that health systems are looking to achieve.”

Evergreen is modeled after Deloitte’s mature services approach developed for Catholic Health Initiatives’ Epic deployment, and builds upon Deloitte’s experience managing other application management services engagements. In addition to the core EHR benefits, Evergreen leverages Deloitte’s advanced analytics and reporting capabilities.

Catholic Health Initiatives (CHI) is the first provider to implement the full Evergreen approach. The company said Evergreen is increasing its ability to capture, analyze and share information, which is paving the way for the organization to be a leader in the areas of evidence-based medicine and care coordination.

“Evergreen is part of our vision to become a forerunner as healthcare moves to a value-based model,” said Michael O’Rourke, CIO at CHI. “It will enhance our ability to deliver the right treatments to the right patients at the right time, with improved quality and reduced costs.”

Beth Walsh,

Editor

Editor Beth earned a bachelor’s degree in journalism and master’s in health communication. She has worked in hospital, academic and publishing settings over the past 20 years. Beth joined TriMed in 2005, as editor of CMIO and Clinical Innovation + Technology. When not covering all things related to health IT, she spends time with her husband and three children.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.